Skip to main content
Clinical Trials/NCT03970629
NCT03970629
Terminated
Not Applicable

ROSA Total Knee Investigational Testing Authorization Study: Prospective Single Center Study of the ROSA Total Knee System

Zimmer Biomet1 site in 1 country19 target enrollmentJune 20, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Pain
Sponsor
Zimmer Biomet
Enrollment
19
Locations
1
Primary Endpoint
Oxford Knee Score Questionnaire
Status
Terminated
Last Updated
3 years ago

Overview

Brief Summary

This is a prospective, single-center clinical study designed to facilitate the collection and evaluation of workflow efficiency, patient pain and function, and adverse event data. This clinical study will include Persona Total Knee components using the ROSA Total Knee Robotic System or conventional instrumentation.

Detailed Description

The primary objective of this study is to collect and compare clinical outcomes and surgical data using the ROSA Total Knee robotic instrumentation and conventional instrumentation in primary total knee arthroplasty. The assessments will include: Planned vs actual component positioning; Workflow efficiency; Patient safety based on incidence and frequency of adverse events; Clinical performance measured by overall pain and function, quality of life data, and radiographic parameters.

Registry
clinicaltrials.gov
Start Date
June 20, 2019
End Date
November 23, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient is a minimum of 18 years of age
  • Pre-op component positioning and sizing plan prior to surgery
  • Independent of study participation, patient is a candidate for primary TKA using the commercially available Persona knee components implanted in accordance with product labeling
  • Patient has participated in this study-related Informed Consent process
  • Patient is willing and able to provide written Informed Consent by signing and dating the IRB or EC approved Informed Consent form
  • Patient is willing and able to complete scheduled study procedures and follow-up evaluations

Exclusion Criteria

  • Patient is currently participating in any other surgical intervention studies or pain management studies
  • Patient has underwent contralateral UKA or TKA within the last 18 months
  • Hip pathology with significant bone loss (e.g. avascular necrosis of the femoral head with collapse, severe dysplasia of the femoral head or the acetabulum)
  • Hip pathology severely limiting range of motion (e.g. arthrodesis, severe contracture, chronic severe dislocation)
  • Patient is pregnant or considered a member of a protected population (e.g., prisoner, mentally incompetent, etc.)
  • Patient has previously received partial or total knee arthroplasty for the ipsilateral knee

Outcomes

Primary Outcomes

Oxford Knee Score Questionnaire

Time Frame: 1 year

Oxford Knee Score

EQ-5D questionnaire

Time Frame: 1 year

EQ-5D

Study Sites (1)

Loading locations...

Similar Trials